Algo version: 0.98b
Mayinglong Pharmaceutical is listed at the SHH Exchange
Mayinglong Pharmaceutical [600993.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Mayinglong Pharmaceutical stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Mayinglong Pharmaceutical pays dividends. Last time was Friday 26th of July 2024 where the investors holding the stock on Friday 26th of July 2024 were paid CNY0.4 per share. Over the last 21 times between 2005 and 2024, Mayinglong Pharmaceutical has paid CNY5.541465 with an average of CNY0.26 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Mayinglong Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY17.86, you would have made a profit of CNY5.88 per share or 32.92%

Yes, the average daily trading liquidity for Mayinglong Pharmaceutical is CNY4.45 million. You should therefore be able to get in and out of your positions relatively fast.

Mayinglong Pharmaceutical has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 3.29, the company's ability to pay off the debt is good. Mayinglong Pharmaceutical has a good net profit margin of 13.95% and should have high tolerances against inflation.

We have calculated the inflation risk for Mayinglong Pharmaceutical to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.